Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
作者信息
Grommes Christian
机构信息
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Neurology, Weill Cornell Medical College, New York, NY.
出版信息
J Clin Oncol. 2023 Mar 20;41(9):1649-1651. doi: 10.1200/JCO.22.02605. Epub 2023 Jan 20.
Abstract
摘要
相似文献
1
Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?血液中的循环肿瘤DNA：原发性中枢神经系统淋巴瘤的新前沿？
J Clin Oncol. 2023 Mar 20;41(9):1649-1651. doi: 10.1200/JCO.22.02605. Epub 2023 Jan 20.
2
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.脑脊液中无肿瘤细胞DNA检测用于原发性中枢神经系统淋巴瘤的诊断
Acta Neuropathol Commun. 2019 Mar 18;7(1):43. doi: 10.1186/s40478-019-0692-8.
3
Clinical applications of circulating tumor DNA in central nervous system lymphoma.循环肿瘤 DNA 在中枢神经系统淋巴瘤中的临床应用。
Semin Hematol. 2023 Jul;60(3):150-156. doi: 10.1053/j.seminhematol.2023.06.007. Epub 2023 Jul 4.
4
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.复发/难治性中枢神经系统淋巴瘤的伊布替尼为基础的联合治疗的 1b 期试验。
Blood. 2019 Jan 31;133(5):436-445. doi: 10.1182/blood-2018-09-875732. Epub 2018 Dec 19.
5
Primary CNS lymphoma.原发性中枢神经系统淋巴瘤。
Nat Clin Pract Neurol. 2007 Jan;3(1):24-35. doi: 10.1038/ncpneuro0395.
6
Differential gene expression in central nervous system lymphoma.中枢神经系统淋巴瘤中的差异基因表达
Blood. 2009 Jan 1;113(1):266-7; author reply 267-8. doi: 10.1182/blood-2008-04-152835.
7
Low-grade central nervous system lymphoma: clarity through a hazy lens.低度恶性中枢神经系统淋巴瘤：透过模糊镜片看清真相
Ann Neurol. 2006 May;59(5):9A-10A. doi: 10.1002/ana.20876.
8
TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium.原发性中枢神经系统淋巴瘤中的端粒酶逆转录酶（TERT）启动子突变与胼胝体的空间分布有关。
Acta Neuropathol. 2015 Sep;130(3):439-40. doi: 10.1007/s00401-015-1461-9. Epub 2015 Jul 21.
9
Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma.调节B细胞受体通路的基因在原发性中枢神经系统淋巴瘤中经常发生突变。
Acta Neuropathol. 2012 Dec;124(6):905-6. doi: 10.1007/s00401-012-1064-7. Epub 2012 Nov 9.
10
Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.基于阵列的淋巴瘤细胞 DNA 甲基化组分析不能明确区分中枢神经系统原发性淋巴瘤和非中枢神经系统弥漫性大 B 细胞淋巴瘤。
Genes Chromosomes Cancer. 2019 Jan;58(1):66-69. doi: 10.1002/gcc.22687. Epub 2018 Nov 29.
引用本文的文献
1
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study.信迪利单抗（抗 PD-1 抗体）联合大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗（抗 CD20 抗体）治疗原发性中枢神经系统淋巴瘤：一项 2 期研究。
Signal Transduct Target Ther. 2024 Sep 4;9(1):229. doi: 10.1038/s41392-024-01941-x.
2
Liquid biopsy in hematological malignancies: current and future applications.血液系统恶性肿瘤中的液体活检：当前及未来应用
Front Oncol. 2023 Apr 20;13:1164517. doi: 10.3389/fonc.2023.1164517. eCollection 2023.
本文引用的文献
1
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.循环肿瘤 DNA 分析在脑淋巴瘤的检测、风险分层和分类中的应用。
J Clin Oncol. 2023 Mar 20;41(9):1684-1694. doi: 10.1200/JCO.22.00826. Epub 2022 Dec 21.
2
Use of circulating tumor DNA to guide treatment of primary central nervous system lymphoma: a case report.利用循环肿瘤DNA指导原发性中枢神经系统淋巴瘤的治疗：一例报告
Neurooncol Adv. 2021 Sep 25;3(1):vdab143. doi: 10.1093/noajnl/vdab143. eCollection 2021 Jan-Dec.
3
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.通过对循环肿瘤DNA中阶段性变异进行靶向测序增强对微小残留病的检测。
Nat Biotechnol. 2021 Dec;39(12):1537-1547. doi: 10.1038/s41587-021-00981-w. Epub 2021 Jul 22.
4
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.MYD88 L265P 突变和脑脊液中白细胞介素-10 的检测是原发性中枢神经系统淋巴瘤患者具有高度特异性的鉴别标志物：一项前瞻性研究的结果。
Br J Haematol. 2021 May;193(3):497-505. doi: 10.1111/bjh.17357. Epub 2021 Feb 23.
5
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.脑脊液无细胞游离循环肿瘤 DNA 可检测和监测 B 细胞淋巴瘤中枢神经系统受累。
Haematologica. 2021 Feb 1;106(2):513-521. doi: 10.3324/haematol.2019.241208.
6
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.脑脊液中无肿瘤细胞DNA检测用于原发性中枢神经系统淋巴瘤的诊断
Acta Neuropathol Commun. 2019 Mar 18;7(1):43. doi: 10.1186/s40478-019-0692-8.
7
L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.L265P 突变和缺失是原发性中枢神经系统弥漫性大 B 细胞淋巴瘤的早期突变事件。
Blood Adv. 2019 Feb 12;3(3):375-383. doi: 10.1182/bloodadvances.2018027672.
8
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.复发/难治性中枢神经系统淋巴瘤的伊布替尼为基础的联合治疗的 1b 期试验。
Blood. 2019 Jan 31;133(5):436-445. doi: 10.1182/blood-2018-09-875732. Epub 2018 Dec 19.
9
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.循环肿瘤 DNA 测量作为弥漫性大 B 细胞淋巴瘤的早期预后预测指标。
J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.
10
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.液活检中用于原发性中枢神经系统淋巴瘤诊断的分子分析：文献回顾与未来机遇
Crit Rev Oncol Hematol. 2018 Jul;127:56-65. doi: 10.1016/j.critrevonc.2018.05.010. Epub 2018 May 17.
Zotero 插件